Thrombosis Adviser News
http://www.thrombosisadviser.com
Rivaroxaban Tied to Lower Brain Bleed Risk in A-Fib
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Rivaroxaban+Tied+to+Lower+Brain+Bleed+Risk+in+A-Fib#news1060
2012-02-03Apixaban more effective than aspirin in reducing stroke recurrence
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Apixaban+more+effective+than+aspirin+in+reducing+stroke+recurrence#news1059
2012-02-03Decision Support Tools Help Optimize Acute PE Detection
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Decision+Support+Tools+Help+Optimize+Acute+PE+Detection#news1058
2012-02-03ACE Inhibitors Not Linked to Improved Outcomes After ACS
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=ACE+Inhibitors+Not+Linked+to+Improved+Outcomes+After+ACS#news1057
2012-02-03Rates of VTE after surgery vary by procedure type
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Rates+of+VTE+after+surgery+vary+by+procedure+type#news1056
2012-01-23Warfarin Patients With Head Trauma Need Second CT Scan
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Warfarin+Patients+With+Head+Trauma+Need+Second+CT+Scan#news1055
2012-01-23New AF ablation consensus doc previewed at Boston AF symposium
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=New+AF+ablation+consensus+doc+previewed+at+Boston+AF+symposium#news1054
2012-01-11Dabigatran Tied to Increase in Heart Attack Risk
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Dabigatran+Tied+to+Increase+in+Heart+Attack+Risk#news1053
2012-01-11Fondaparinux Reduces Events From Superficial Vein Thromboses
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Fondaparinux+Reduces+Events+From+Superficial+Vein+Thromboses#news1052
2012-01-11Risk for very late stent thrombosis, late TLR rose steadily up to 5 years after stenting
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Risk+for+very+late+stent+thrombosis%2C+late+TLR+rose+steadily+up+to+5+years+after+stenting#news1051
2012-01-11Heparin Bridging Associated With Increased Bleeding Risk
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Heparin+Bridging+Associated+With+Increased+Bleeding+Risk#news1050
2012-01-06Enoxaparin failed to reduce mortality in acutely ill patients
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Enoxaparin+failed+to+reduce+mortality+in+acutely+ill+patients#news1049
2012-01-05Rivaroxaban approved in Europe for AF and DVT treatment
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Rivaroxaban+approved+in+Europe+for+AF+and+DVT+treatment#news1048
2011-12-20Malaysia the first Asian country to use stroke medication
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Malaysia+the+first+Asian+country+to+use+stroke+medication#news1047
2011-12-19ASH: Rivaroxaban Better in Practice than Expected
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=ASH%3A+Rivaroxaban+Better+in+Practice+than+Expected#news1046
2011-12-15ASH: Catheter-Directed Thrombolysis Cuts DVT Risks
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=ASH%3A+Catheter-Directed+Thrombolysis+Cuts+DVT+Risks#news1045
2011-12-15Warfasa: Aspirin associated with 40% reduced risk for unprovoked VTE recurrence
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Warfasa%3A+Aspirin+associated+with+40%25+reduced+risk+for+unprovoked+VTE+recurrence#news1044
2011-12-15Blood clot risk halved for patients checking own warfarin dose
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Blood+clot+risk+halved+for+patients+checking+own+warfarin+dose#news1043
2011-12-02NEJM: Warfarin culprit for most hospitalizations in elderly; management may help
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=NEJM%3A+Warfarin+culprit+for+most+hospitalizations+in+elderly%3B+management+may+help#news1042
2011-12-01Patients With Autoimmune Disorders Have Higher Risk Of Pulmonary Embolism
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=Patients+With+Autoimmune+Disorders+Have+Higher+Risk+Of+Pulmonary+Embolism#news1041
2011-12-01ELEVATE-TIMI 52: High-dose clopidogrel reduced platelet reactivity in CYP2C19*2 carriers
http://www.thrombosisadviser.com/scripts/pages/en/resources/newsticker/index.php?WT.cusRSSfeedLink=ELEVATE-TIMI+52%3A+High-dose+clopidogrel+reduced+platelet+reactivity+in+CYP2C19%2A2+carriers#news1040
2011-11-16